• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

  Vitamin C supplementation in pregnancy improves respiratory function in children of smoking mothers at 5 years of age

byVincent SoandAlex Gipsman, MD
December 7, 2022
in Chronic Disease, Obstetrics, Pediatrics, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a randomized clinical trial, vitamin C supplementation in pregnancy improved measures of pulmonary function tests at 5 years of age in children born to smoking mothers.

2. Vitamin C supplementation in pregnancy was associated with decreased occurrences of wheezing in children at 5 years of age and had greater benefits when started earlier in pregnancy (<18 weeks gestation).

Evidence Rating Level: 1 (Excellent)

Study Rundown: In utero smoke exposure has been shown to affect fetal lung development, airway function, and risk of wheezing and asthma in childhood. Despite anti-smoking efforts, many individuals continue to smoke during pregnancy. Interestingly, some data provide evidence that vitamin C supplementation in pregnant smokers improves infant pulmonary function test (PFT) measures up to 12 months of age, but no studies have studied potential benefits in the preschool age group. In this study, the same authors reconsented participants at 5 years of age (n=213), to assess differences in PFT parameters and respiratory questionnaires in the placebo group and the group treated with maternal vitamin C. They found that those born to mothers treated with vitamin C during pregnancy had better pulmonary function at 5-6 years of age. Additionally, the vitamin C supplementation group had fewer wheezing episodes in the preschool years, and a greater benefit was seen when Vitamin C supplementation was started earlier in pregnancy. One limitation of this design is the omission of non-smoking groups. Therefore, it remains unclear if maternal vitamin C supplementation positively benefits childhood pulmonary function regardless of maternal smoking status. Overall, this study provides evidence that maternal vitamin C supplementation improves offspring’s pulmonary function and reduces the frequency of wheezing during preschool age. However, additional studies are required to validate these findings in external cohorts before incorporating supplementation into routine clinical practice.

Click here to read the article in JAMA Pediatrics

Relevant Reading: Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial

RELATED REPORTS

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

Depemokimab therapy reduces exacerbations in patients with severe eosinophilic asthma

In-Depth [randomized controlled trial]: Using a double-blind placebo-controlled design, this study reconsented participants from the original Vitamin C to Decrease the Effects of Smoking in Pregnancy (VCSIP) trial that enrolled women >15 years old with a singleton gestation between 13-22 gestational weeks who were current smokers (≥1 cigarette in the last week). Participants were randomized to two groups: (1) the placebo group or (2) the treatment group taking 500 mg/day of vitamin C between December 2012 and June 2015. Fasting plasma ascorbic acid levels were measured in mid and late gestation at follow-up appointments and were higher in the vitamin C group, thus confirming general adherence. This follow-up study reconsented participants with 213 children of 251 pregnant smokers with a follow-up period up to the child’s sixth birthday, with data collection completed in December 2021. Measurements and outcomes included pulmonary function tests (PFTs), and respiratory questionnaires to assess the occurrence of wheezing. Of the spirometry performed, the vitamin C group had greater FEF25-75 (p<0.001), FEF50 (p<0.001), FEF75 (p<0.001), FEV1 (p<0.02), and metrics correlated with airway growth (FEF25-75 to FVC ratio, p<0.001). The measure of FVC did not differ between groups. Children from women treated with vitamin C had a significantly lower frequency of wheezing between the fourth and sixth birthday (OR 0.41, 95% CI 0.23-0.74, p=0.003). In addition, the effect of vitamin C on wheezing was associated with gestational age, with mothers receiving vitamin C before 18 weeks of gestation demonstrating the largest benefit (OR 0.22, 95% CI 0.09-0.054, p=0.001) in a sub-analysis comparing groups treated before and after 18 weeks of gestation.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: asthmasmokingvitamin cvitamin supplementationwheezing
Previous Post

Parent decision making in poor-prognosis childhood cancer may extend beyond values and preferences

Next Post

Deferiprone is associated with worsening Parkinson’s symptoms in patients naïve to dopaminergic drugs

RelatedReports

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

May 19, 2025
Teen asthma controller medication adherence affected by risk tolerance
Chronic Disease

Depemokimab therapy reduces exacerbations in patients with severe eosinophilic asthma

March 4, 2025
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Characterization of increased cryptogenic ischemic stroke risk from smoking

May 19, 2025
Next Post
Brain lesions on MRI linked with subsequent increased stroke risk

Deferiprone is associated with worsening Parkinson’s symptoms in patients naïve to dopaminergic drugs

Contrast-induced nephropathy may be less common than previously reported

Discontinuing RAS inhibitors in advanced chronic kidney disease does not impact long-term outcomes

Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression

Two bedaquiline-containing regimens had superior efficacy and safety profiles for treatment of rifampin-resistant tuberculosis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Effectiveness and user experiences of a valgus brace in patients with knee osteoarthritis: A mixed-method randomised controlled trial
  • Artificial intelligence accelerates drug discovery and reduces animal testing
  • Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.